cat |
LDLo |
intravenous |
70mg/kg (70mg/kg) |
|
"Structure et Activite Pharmacodyanmique des Medicaments du Systeme Nerveux Vegetatif," Bovet, D., and F. Bovet-Nitti, New York, S. Karger, 1948Vol. -, Pg. 483, 1948. |
cat |
LDLo |
subcutaneous |
130mg/kg (130mg/kg) |
|
Journal of Pharmacology and Experimental Therapeutics. Vol. 60, Pg. 1, 1937. |
dog |
LDLo |
intravenous |
50mg/kg (50mg/kg) |
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
BEHAVIORAL: MUSCLE WEAKNESS
GASTROINTESTINAL: NAUSEA OR VOMITING |
Proceedings of the Society for Experimental Biology and Medicine. Vol. 40, Pg. 244, 1939. |
dog |
LDLo |
unreported |
60mg/kg (60mg/kg) |
|
"Structure et Activite Pharmacodyanmique des Medicaments du Systeme Nerveux Vegetatif," Bovet, D., and F. Bovet-Nitti, New York, S. Karger, 1948Vol. -, Pg. 513, 1948. |
frog |
LDLo |
intramuscular |
750mg/kg (750mg/kg) |
BEHAVIORAL: EXCITEMENT
BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY)
LUNGS, THORAX, OR RESPIRATION: DYSPNEA |
Proceedings of the Society for Experimental Biology and Medicine. Vol. 40, Pg. 244, 1939. |
frog |
LDLo |
subcutaneous |
1gm/kg (1000mg/kg) |
|
"Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1311, 1935. |
guinea pig |
LD50 |
intraperitoneal |
400mg/kg (400mg/kg) |
|
Journal of Pharmacology and Experimental Therapeutics. Vol. 105, Pg. 166, 1952. |
guinea pig |
LD50 |
oral |
1100mg/kg (1100mg/kg) |
|
Journal of Pharmacology and Experimental Therapeutics. Vol. 105, Pg. 166, 1952. |
human |
TDLo |
intramuscular |
1ug/kg (0.001mg/kg) |
SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE |
"Possible Long-Term Health Effects of Short-Term Exposure to Chemical Agents," National Research Council, 3 vols., Washington, DC, National Academy Press, 1982-85Vol. 1, Pg. L1, 1982. |
human |
TDLo |
oral |
33ug/kg (0.033mg/kg) |
SENSE ORGANS AND SPECIAL SENSES: VISUAL FIELD CHANGES: EYE
BEHAVIORAL: MUSCLE WEAKNESS |
Journal of Toxicology, Clinical Toxicology. Vol. 22, Pg. 581, 1984/1985. |
man |
LDLo |
unreported |
143ug/kg (0.143mg/kg) |
|
"Structure et Activite Pharmacodyanmique des Medicaments du Systeme Nerveux Vegetatif," Bovet, D., and F. Bovet-Nitti, New York, S. Karger, 1948Vol. -, Pg. 482, 1948. |
man |
TDLo |
intramuscular |
175ug/kg (0.175mg/kg) |
BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS" |
Federation Proceedings, Federation of American Societies for Experimental Biology. Vol. 32, Pg. 250, 1973. |
man |
TDLo |
intravenous |
14ug/kg (0.014mg/kg) |
BEHAVIORAL: HEADACHE
VASCULAR: BP ELEVATION NOT CHARACTERIZED IN AUTONOMIC SECTION |
Annals of Internal Medicine. Vol. 101, Pg. 720, 1984. |
mouse |
LD50 |
intradermal |
550mg/kg (550mg/kg) |
BEHAVIORAL: EXCITEMENT
BEHAVIORAL: ATAXIA
LUNGS, THORAX, OR RESPIRATION: DYSPNEA |
Archives Internationales de Pharmacodynamie et de Therapie. Vol. 59, Pg. 149, 1938. |
mouse |
LD50 |
intraperitoneal |
30mg/kg (30mg/kg) |
|
Journal of Medicinal Chemistry. Vol. 31, Pg. 683, 1988. |
mouse |
LD50 |
intravenous |
30mg/kg (30mg/kg) |
|
Journal of Medicinal Chemistry. Vol. 28, Pg. 1760, 1985. |
mouse |
LD50 |
oral |
75mg/kg (75mg/kg) |
BEHAVIORAL: EXCITEMENT
LUNGS, THORAX, OR RESPIRATION: DYSPNEA
BEHAVIORAL: ATAXIA |
Archives Internationales de Pharmacodynamie et de Therapie. Vol. 59, Pg. 149, 1938. |
mouse |
LD50 |
subcutaneous |
428mg/kg (428mg/kg) |
|
Zhongcaoyao. Chinese Traditional and Herbal Medicine. Vol. 11, Pg. 457, 1980. |
rabbit |
LD50 |
intradermal |
500mg/kg (500mg/kg) |
BEHAVIORAL: EXCITEMENT
BEHAVIORAL: ATAXIA
LUNGS, THORAX, OR RESPIRATION: DYSPNEA |
Archives Internationales de Pharmacodynamie et de Therapie. Vol. 59, Pg. 149, 1938. |
rabbit |
LD50 |
intravenous |
50mg/kg (50mg/kg) |
BEHAVIORAL: EXCITEMENT
BEHAVIORAL: ATAXIA
LUNGS, THORAX, OR RESPIRATION: DYSPNEA |
Archives Internationales de Pharmacodynamie et de Therapie. Vol. 59, Pg. 149, 1938. |
rabbit |
LD50 |
oral |
600mg/kg (600mg/kg) |
BEHAVIORAL: EXCITEMENT
BEHAVIORAL: ATAXIA
LUNGS, THORAX, OR RESPIRATION: DYSPNEA |
Archives Internationales de Pharmacodynamie et de Therapie. Vol. 59, Pg. 149, 1938. |
rabbit |
LDLo |
intraperitoneal |
350ug/kg (0.35mg/kg) |
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION
CARDIAC: PULSE RATE |
Journal of Pharmacology and Experimental Therapeutics. Vol. 60, Pg. 14, 1937. |
rabbit |
LDLo |
subcutaneous |
500mg/kg (500mg/kg) |
|
"Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1311, 1935. |
rat |
LD50 |
intramuscular |
920mg/kg (920mg/kg) |
|
Drug and Chemical Toxicology. Vol. 1, Pg. 355, 1978. |
rat |
LD50 |
intraperitoneal |
280mg/kg (280mg/kg) |
|
Journal of Pharmacology and Experimental Therapeutics. Vol. 105, Pg. 166, 1952. |
rat |
LD50 |
intravenous |
73mg/kg (73mg/kg) |
|
Schweizerische Medizinische Wochenschrift. Vol. 76, Pg. 1282, 1946. |
rat |
LD50 |
oral |
500mg/kg (500mg/kg) |
|
Archives Internationales de Pharmacodynamie et de Therapie. Vol. 155, Pg. 393, 1965. |
rat |
LD50 |
subcutaneous |
250mg/kg (250mg/kg) |
|
Archives Internationales de Pharmacodynamie et de Therapie. Vol. 68, Pg. 339, 1942. |